Literature DB >> 19222990

Characterization of a negative feedback network between SUMO4 expression and NFkappaB transcriptional activity.

Cong-Yi Wang1, Ping Yang, Manyu Li, Feili Gong.   

Abstract

Previously, we have demonstrated evidence suggesting that SUMO4 negatively regulates NFkappaB transcriptional activity, probably through sumoylation of IkappaBalpha. Here, we present data indicating that SUMO4 possesses the capacity to conjugate to IkappaBalpha. Luciferase reporter assays in 3T3 cells deficient for IkappaBalpha further demonstrated that SUMO4 regulates NFkappaB signaling dependent on its sumoylation of IkappaBalpha. More importantly, a putative NFkappaB binding motif has been characterized within the SUMO4 promoter. Subsequent promoter reporter assays revealed that SUMO4 promoter with disrupted NFkappaB binding motif failed to response to NFkappaB specific IL-1beta stimulation. ChIP assays showed that NFkappaB binds to SUMO4 promoter and activates its transcription. Together, our data suggest that SUMO4 may act as a negative feedback regulator to prevent excessive activation of NFkappaB. Given the importance of NFkappaB signaling in immune response, SUMO4 could play a role to tightly control the potency of immune response to prevent autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222990     DOI: 10.1016/j.bbrc.2009.02.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic rats.

Authors:  Sijiao Chen; Tao Yang; Furong Liu; Hongyan Li; Yinghua Guo; Hongyan Yang; Jinchun Xu; Jindan Song; Zhiming Zhu; Daoyan Liu
Journal:  Inflamm Res       Date:  2013-10-31       Impact factor: 4.575

2.  Association of SUMO4 Met55Val variation with increased insulin resistance in newly diagnosed type 2 diabetes in a Chinese population.

Authors:  Zhenzhong Ji; Zhe Dai; Yan Huang; Hedson Alves Martins; Yancheng Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

Review 3.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

Review 4.  SUMO--a post-translational modification with therapeutic potential?

Authors:  Chang-Hoon Woo; Jun-Ichi Abe
Journal:  Curr Opin Pharmacol       Date:  2010-01-14       Impact factor: 5.547

5.  SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses.

Authors:  Ping Yang; Yushan Zhang; Junfa Xu; Shu Zhang; Qilin Yu; Junfeng Pang; Xiaoquan Rao; Michal Kuczma; Mario B Marrero; David Fulton; Piotr Kraj; Yunchao Su; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

6.  Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IκBα.

Authors:  Hong Jiang; Ping He; Junxia Xie; Matthias Staufenbiel; Rena Li; Yong Shen
Journal:  Hum Mol Genet       Date:  2014-05-13       Impact factor: 6.150

7.  In vitro phenotypic, genomic and proteomic characterization of a cytokine-resistant murine β-TC3 cell line.

Authors:  Antonina Coppola; Laura Tomasello; Giuseppe Pizzolanti; Ida Pucci-Minafra; Nadia Albanese; Gianluca Di Cara; Patrizia Cancemi; Maria Pitrone; Alessandra Bommarito; Elvira Carissimi; Giovanni Zito; Angela Criscimanna; Aldo Galluzzo; Carla Giordano
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Adiponectin receptor 1 and small ubiquitin-like modifier 4 polymorphisms are associated with risk of coronary artery disease without diabetes.

Authors:  Hong Li; Ze Yang; Lian-Mei Pu; Xiang Li; Yang Ruan; Fan Yang; Shuai Meng; Duo Yang; Wei Yao; Hao Fu; Feng Zhang; Ze-Ning Jin
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

9.  Enhanced apoptosis of monocytes from complication-free juvenile-onset diabetes mellitus type 1 may be ameliorated by TNF-α inhibitors.

Authors:  Jolanta Myśliwska; Monika Ryba-Stanisławowska; Marcin Smardzewski; Bartosz Słomiński; Małgorzata Myśliwiec; Janusz Siebert
Journal:  Mediators Inflamm       Date:  2014-06-02       Impact factor: 4.711

Review 10.  The role of ubiquitination and sumoylation in diabetic nephropathy.

Authors:  Chenlin Gao; Wei Huang; Keizo Kanasaki; Yong Xu
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.